The Congressional Budget Office set the stage for the House Ways & Means Committee hearing Thursday (Oct. 17) on drug pricing legislation with its estimate of $345 billion in taxpayer savings over seven years from government drug price negotiation. Those for and against government price setting are using CBO’s preliminary projections to make their cases. Democrats said it shows Americans are getting ripped off and would save a lot of money by following the lead of other developed countries, while...